Short or rapid-acting insulin analogues allow a better postprandial glucose control and reduce hypoglycaemic risk. Clinical trials with insulin aspart and insulin lispro have demonstrated improved postprandial glucose control in comparison with human insulin, however, studies directly comparing the activities...
Humalog® (insulin lispro) Eli Lilly Clear 20 - 45 minutes 60 - 120 minutes 4 - 5 hours Admelog® (insulin lispro) Sanofi Clear 20 - 45 minutes 45 - 150 minutes 3.5 - 4.75 hours Short Acting Regular(Humulin, Actrapid, Velosulin®) Eli Lilly and Novo Nordisk Clear 30 minutes...
A rapid-acting analog insulin may be used to increase the insulin absorption rate in subcutaneous insulin. How long does intravenous insulin last in the body? Intravenous insulin acts rapidly and lasts for a very short duration in the body. To maintain the desired glucose levels in the blood,...